key: cord-0303517-5s7jgdz1
authors: Shi, Ruona; Feng, Zhenhuan; Zhang, Xiaofei
title: Integrative multi-omics landscape of non-structural protein 3 of severe acute respiratory syndrome coronaviruses
date: 2021-07-19
journal: bioRxiv
DOI: 10.1101/2021.07.19.452910
sha: 1c02756356dcfd77a5baddabc673430be72fd842
doc_id: 303517
cord_uid: 5s7jgdz1

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is currently a global pandemic. Extensive investigations have been performed to study the clinical and cellular effects of SARS-CoV-2 infection. Mass spectrometry-based proteomics studies have revealed the cellular changes due to the infection and identified a plethora of interactors for all SARS-CoV-2 components, except for the longest non-structural protein 3 (NSP3). Here, we expressed the full-length NSP3 proteins of SARS-CoV and SARS-CoV-2 to investigate their unique and shared functions using multi-omics methods. We conducted interactome, phosphoproteome, ubiquitylome, transcriptome, and proteome analyses of NSP3-expressing cells. We found that NSP3 plays essential roles in cellular functions such as RNA metabolism and immune response such as NF-κB signal transduction. Interestingly, we showed that SARS-CoV-2 NSP3 has both endoplasmic reticulum and mitochondrial localizations. In addition, SARS-CoV-2 NSP3 is more closely related to mitochondrial ribosomal proteins, whereas SARS-CoV NSP3 is related to the cytosolic ribosomal proteins. In summary, our multi-omics studies of NSP3 enhance our understanding of the functions of NSP3 and offer valuable insights for the development of anti-SARS strategies.

Introduction enrichment analysis, we found that RELB-, NF-kB1-, and NF-kB2-binding motifs were highly 294 represented in the upregulated DEGs, whereas ZBTB7A-, ZBTB7B-and AFF4-binding motifs 295 were enriched in the downregulated DEGs ( Figure 7A ). We then matched the top 1000 variable 296 genes of our gene sets with C2 (chemical and genetic perturbations sub-collection) and C5 (GO 297 sub-collection) collections from the Molecular Signature Database (MsigDB) [41, 42] . As shown 298

in Figure 7B , our upregulated genes were correlated with multiple reported gene sets, and a large 299 portion of them was related to perturbations in NF-kB signaling. More importantly, our gene sets 300 had a significant correlation with that of SARS-CoV-2 infection of Calu-3 and A549 cells and 301 respiratory syncytial virus infection of A549 cells. 302

Our proteomics (interactome, phosphoproteome, and ubiquitylome) analysis identified the 303 significant enrichment of proteins related to mRNA splicing. Therefore, we performed the 304 alternative splicing analyses of our transcriptome results. We observed 381 and 514 alternative 305 splicing events in CoV2-NSP3-and CoV1-NSP3-expressing cells, respectively ( Figure 7C) . 306

Among them, a large portion of altered splicing events was detected on the exon cassette and intron 307 retention region, indicating that both NSP3 proteins alter host cell RNA processing. 308

Further, we performed FASP-based proteome analysis of NSP3-expressing cells in parallel. 309

Differentially expressed proteins (DEPs) were calculated with thresholds of FDR < 0.05, and 310 |L2FC| > 1 ( Figure 7D ). Among them, we found that a known target of CoV1-NSP3, TP53, was 311 downregulated by both NSP3 proteins, and this downregulation was not CS-dependent [43] . 312

Unfortunately, no significant GO terms or pathways were enriched for these DEPs. We compared 313 our results with the proteome data after SARS-CoV-2 infection reported by Bojkova and 314 colleagues [44] and highlighted overlapping proteins on the left of the heatmap ( Figure 7D) . A 315 comparison of transcriptome and proteome data revealed that NF-kB2 was upregulated at both 316 levels, indicating a positive feedback regulation and highlighting the pivotal roles of NSP3 in NF-317 kB signaling ( Figure 7E) . 318

We combined all of our significant candidates to systematic analysis CoV2-NSP3 regulated 320 cellular events. We included known protein-protein interactions and regulation events to expand 321 the connections of our candidates. Among the many cellular events we found, TP53 was one of 322 the proteins that was extensively regulated by NSP3 ( Figure 8A) . We found interactors, activators, 323 and inhibitors of TP53 in our multi-omics studies. In addition, these regulators were associated with other candidates, further expanding the diffusion network. Therefore, we concluded that 325 NSP3 attacks p53 at multiple levels to circumvent the antiviral defense effects of p53 [43, 45] . 326 Furthermore, the innate immune response, a surveillance system that SARS-CoV-2 needs to evade 327

[46], was determined to be regulated by NSP3 expression ( Figure S10 ). Besides regulating 328 antiviral effects, NSP3 contributes to SARS-CoV-2-induced RNA alternative splicing [34] . We 329 observed that proteins related to RNA splicing are regulated by NSP3 at post-translational levels 330 ( Figure 8B ). For example, the phosphorylation of splicing factors and ubiquitination of 331 heterogeneous nuclear ribonucleoproteins were changed in NSP3 expressing cells. Collectively, 332 these data imply that NSP3 has diverse cellular effects in SARS-CoV-2 infection. 333

Finally, we analyzed our data to identify proteins that were significantly enriched in at least 334 two omics studies of NSP3 expressing cells ( Figure 8C ). In the meantime, we searched these 335 candidate proteins against the drug database drugbank (https://go.drugbank.com/). In total, 13 336 proteins were regulated by two NSP3 proteins, and two (JAK1 and PPP2CA) out of them had nine 337 FDA-approved drugs. Importantly, drugs that target JAK1 and PPP2CA are under investigation 338

for COVID-19 [47] [48] [49] . Therefore, it would be interesting to investigate the antiviral effects of 339 these candidate proteins with FDA-approved drugs. reports demonstrated that PLpro alone is not sufficient to cleave the NSP1-NSP2 polypeptide, and 345

the PLpro domain has a very similar interactome with NSP3 without the transmembrane region, 346

suggesting that the localization and integrity of the NSP3 are important for its function and 347 interaction with host cells [18, 21] . A previous study using deletions showed that CoV2-NSP3 has 348 a general cytosolic localization, which is contradictory to our results [50] . We showed that CoV2-349 NSP3 has both ER and mitochondrial localizations, whereas CoV1-NSP3 localizes to the ER as 350

reported [15] . Therefore, we believe that an interactome study based on NSP3 protein with proper 351 localization is more reliable. By comparing of our results with a recently published interactome 352 study using NSP3 deletions, we found that approximately 20% of interactors are shared between 353 both studies. Importantly, we observed a strong association between NSP3 proteins and ribosomal 354 protein in our study, which is lacking in the previous study.

important to follow the pathogenesis of viral infection, and eventually develop antiviral 357 compounds. Multi-omics methods, such as proteomics-based interaction and proteome studies 358 have been proven to be useful tools for studying virus-host cell interactions [29, 44] . In this study, 359

we combined the interactome, phosphoproteome, transcriptome, proteome and ubiquitylome to 360 provide an integrative landscape of unique and shared functions of the NSP3 proteins. These 361 parallel multi-omics datasets provide a rich resource for future mechanistic studies on how NSP3 362 regulates host cell functions in detail. Overall, we showed that both NSP3 proteins are connected 363 to multiple fundamental cellular functions, including RNA metabolism, the immune response, cell 364 cycle, translation, transcription, and others ( Figure 9 ). These host cellular functions and signaling 365 pathways are also largely affected by SARS-CoV infection [29, 44] , indicating that NSP3 is one 366 of the key polypeptides of SARS-CoVs in attacking host cell functions. Interestingly, multi-omics 367 results showed that although both NSP3 proteins regulate similar cellular functions, they utilize 368 different proteins to achieve these regulatory functions. For example, the CoV2-NSP3 prefers to 369 associated with the mitochondrial translational machinery, whereas CoV1-NSP3 is linked to the 370 cytosolic translational machinery. These results suggest a conserved cellular effect of SARS-CoVs 371 NSP3 during the evolution. 372

Previous studies on SARS-CoV have suggested that the combination of three transmembrane-373 localized NSPs (NSP3, NSP4, and NSP6) induces DMV formation, which together with other 374

NSPs and host cell proteins, forms the RTC. Therefore, the membrane localization of NSP3 might 375 be a key factor that the virus uses to select the organelles for RTC formation. In the present study, 376

we found that unlike CoV1-NSP3, CoV2-NSP3 has two cellular localizations, N-terminal 377 mitochondrial and C-terminal ER localizations. In addition, we showed that the N-terminal 378 enrichment of CoV2-NSP3 extensively results in the immunoprecipitation of mitochondrial 379 proteins. Furthermore, Wu and colleagues [51] showed that the SARS-CoV-2 RNA genome and 380 sgRNAs are enriched in the host mitochondrial matrix using computational modeling. These 381 results suggest that in SARS-CoV-2 infection, NSP3 might exploit both ER and mitochondria to 382 initiate the RTC formation. In addition, we showed that proteins related to mRNA exporting and 383 translation are enriched with both NSP3 proteins. In combination with the fact that the RTC is the 384 location for RNA synthesis, we speculate that NSP3 couples RNA transport and translation 385 together to rapidly synthesize viral proteins. However, we should note that the interaction between ribosomal proteins and NSP3 is not mediated by RNA, as we introduced universal nucleases to 387 our cell lysis processes. 388

In summary, we expressed and studied the localization of NSP3 proteins. We identified a rich 389 candidate resource for studying the functions of NSP3 proteins and provided a systematic analysis 390 of how NSP3 contributes to the regulation of cellular function. Importantly, we showed that 391 although both NSP3 proteins shared extensive similar functions, SARS-CoV-2 NSP3 is different 392 from SARS-CoV NSP3 in its connection with mitochondrial proteins. Moreover, we provided a 393 Immunofluorescence 433

Cells grown on 0.1% gelatin coated coverslips were transfected with indicated plasmid for 36 hr. 434 4% paraformaldehyde was used to fix the cells at room temperature for 30 min followed with 435 quenching with 2 mg/mL glycine. Cells were then permeabilized with 0.2% Triton X-100 and 436 blocked with 10% FBS. Indicated first antibody and second antibody were added for overnight at 437 4℃ and 1 hr. at room temperature, respectively. Cells were mounted with ProLong Gold Antifade 438

Reagent with DAPI (Cell Signaling, 8961S). Images were taken and processed using LSM800 and 439 LSM900 from Zeiss. Antibodies used for the experiment are: CANX (2679, Cell Signaling), 440 TOMM20 (ab56783, Abcam), Flag (F1804 and F7425, Sigma), NSP3 (ab181602, Abcam). 441

Cell cycle and mitochondrial potential experiments were performed using FACS. For cell cycle 443

analysis, approximately 1mL of 1´10 6 /mL cells transfected with indicated plasmids were harvest 444 and fixed with 70% ethanol overnight. 0.1% Triton-X100 was used to permeabilize cells before 445 the staining with propidium iodide for 15 min at room temperature. Cells were analyzed with PE 446 channel using Beckman CytoFLEX. 447

All omics experiments were performed in biological replicates. were then incubated with 100 µL of elution buffer for another 5 min, and the supernatant was 466 collected in the same tube. All these steps were performed at RT in a thermoshaker C at 1500 rpm. 467

Combined elutes were digested with additional 200 ng of trypsin overnight at room temperature. 468

Finally, tryptic peptides were acidified to pH < 2 by adding 10 µL of 10% TFA (Sigma, 469 1002641000). Cell Signaling) was used to enrich K-e-GG peptides. The whole process was performed according 485 to the manufacturer's instruction except in the steps of digestion and peptide desalting. We used 486

Lys-C to digest 3 mg protein in 8M urea buffer for 3 hr. at 37ºC first, and then diluted to 2M urea and trypsinization overnight at 37ºC. For peptide desalting, we used the Blond Elute LRC-C18 488 200 mg column from Agilent (12113024), followed with lyophilization for 2 days. 489

HEK293T cell transfected with indicated plasmids were lysed with 8 M urea with 10 mM DTT, 491 0.1 M pH 8.5 Tris buffer. Soluble cell lysates were collected after 10 cycles of sonication for 30s 492 followed by 30s at 4ºC using a Diagenode Biorupter Pico Sonicator, followed with maximum 493 speed centrifugation at room temperature for 15 min. Whole proteome peptides were prepared 494 using the FASP protocol as described before [53] . In brief, 50 µg of soluble lysates was added 495 onto 30 kDa cut-off filter (MRCF0R030, Millipore) and centrifuged at 11000 rpm at 20ºC for 15 496 min. 50 mM iodoacetamide (IAA, Sigma, I1149) in urea buffer was used to alkylate proteins at 497 20ºC for 15 min. After 3 washes with urea lysis buffer and 3 washes with 50 mM ammonium 498 biocarbonate (ABC) buffer, 500 ng of trypsin in 50 µL 50 mM ABC buffer was used to digest 499 proteins in a wet chamber overnight at 37ºC. Peptides was extracted by 50 mM ABC buffer and 500 acidified to pH < 2 by adding 10 µL of 10% TFA. 501

HEK293T cell transfected with indicated plasmids were harvested and total RNA was isolated 503 using ipureTRizol kit according to manufacturer's instruction (K417, IGEbio). Sequencing 504 libraries were generated using Next UltraTM RNA Library Prep Kit for Illumina (E7760, NEB) 505 following manufacturer's recommendations. In brief, mRNA was captured using mRNA capture 506 beads, followed with fragmentation and cDNA synthesize using random hexamers. DNA clean 507 beads was used to purified dsDNA after the second strand synthesis, followed with end repairing, 508

A tailing, adapter ligation, PCR amplification and library purification. Sequencing was done by 509

Illumina NovaSeq platform (IGEbio, China) . 510

Desalted peptides were separated and analyzed with an Easy-nLC 1200 connected online to Fusion 512

Lumos or Fusion Eclipse (cross-linking experiment) mass spectrometer equipped with FAIMS pro 513 using different gradient of buffer B (80% acetonitrile and 0.1% Formic acid). For interactome 514 study, a gradient of total 140 min of 100 min 2% to 22%, 20 min 22% to 28%, 12 min 28% to 36% 515 and 8 min 100% of buffer B was used; for proteome and ubiquitylome analysis, a gradient of total 516 240 min of 1 min of 2%, 10 min 2% to 7%, 200 min 7% to 28%, 15 min 28% to 36%, 5 min 36% 517 to 60% and 7 min 95% of buffer B was used; for phosphoproteome analysis, a gradient of total 518 120 min of 80 min 2% to 22%, 20 min 22% to 28%, 12 min 28% to 40% and 8 min 95% of buffer 519 B was used. Data dependent analysis was used as data acquisition mode. Detailed information 520 about the gradient and the setting of the MS can be found in the raw files. Raw data were first 521 transformed using FAIMS MzXML Generator and then analyzed using MaxQuant version 522 1.6.17.0 [54] search against Human Fasta database with CoV1-NSP3 and CoV2-NSP3 protein 523 sequences. Label free quantification and match between runs functions were enabled for all 524 analyses. For phosphoproteome and ubiquitylome analyses, pSTY and Gly-Gly (K, not C-term) in 525 variable modifications were added. 526

PCA for all omics studies were performed using top 1000 variable events with maximum standard 528 deviation of NSP3-expressing cells. PC1-PC2 scatterplot exhibits the magnitude of the difference 529 between samples. 530

The MaxQuant output files "proteinGroup" was used for the subsequent analysis of proteome and 532

interactome. We filtered out the protein that labelled as reverse or potential contaminant, and 533 analyzed the non-crosslinking interactome and proteome data using DEP [55] . The significant 534 thresholds were L2FC > 2, FDR < 0.001 for interactome, and |L2FC| > 1, FDR < 0.05 for proteome 535 analyses. For crosslinking interactome analysis, we used an alternative method described before, 536 which used a variable filter combining log2 fold-change (enrichment) and adjusted P value [56] . 537

Briefly, to determine enriched interactors, we used a cutoff lines with the function y > c/(x -x0) 538 on scatters where x is the log2 fold-change and y is adjusted P value (c = curvature, x0 = minimum 539 fold change). The distribution of log2 fold-changes between NSP3s overexpression and EGFP 540 control were fitted to a Gaussian curve using least squares fitting (excluding outliers) to determine 541 the standard deviation σ. We set a stringent fold-change cutoff x0 to 2 σ while selected a relatively Circos plots was performed using circlize package [59] . 548

The MaxQuant output files designated "Phospho(STY)sites" was used for testing intensity 550 differences of phosphosites between control and NSP3 expressing cells. We performed Student's 551 t test as two-sample-test and one-way analysis of variance (ANOVA) test following Tukey's 552 significant honest difference post-hoc test (THSD) as multiple-sample-test. P values were adjusted 553 by Benjamini & Hochberg (BH) method. We defined peptide with p-adjusted < 0.01, |L2FC| > 2 554 and localization possibility > 0.7 as significant enriched peptide. 555

To study change of kinase activities, we ranked phosphosites by L2FC and performed Kinase-556

Substrate Enrichment Analysis (KSEA) using KSEAapp package [60] in combination with a 557

reported kinase-substrate relationship [61] . We filtered out the kinases of which matching sites 558 was less than 3 or Z-score is lower than 1 and created Human Kinome Tree illustration using 559

KinMap [36] . The targeting drugs that regulate activity changed kinases were extracted from 560 drugbank (https://go.drugbank.com/). 561

The ubiquitylome data was analyzed as described for phosphoproteome. Here, we defined peptide 563 with adjusted p < 0.001, |L2FC| > 2 and localization possibility > 0.7 as significant enriched 564 peptide. 565

Raw reads were aligned to the human genome (hg38) using HISAT2 [62]. Next, we assembled 567 reads to transcripts and quantified the read counts of each genes utilizing StringTie [63]. Lowly 568 expressed genes were filtered out using a CPM (counts per million) threshold. We kept genes that 569 CPM is greater than 1 in at least 2 samples and analyzed the differential expression gene using 570 edgeR [64]. Top 1000 upregulated and 1000 downregulated genes were ordered by L2FC as the 571 gene list input of GSEA analysis. Differentially expressed genes (DEGs) between control and 572 NSP3 expressing cells were characterized for each sample with thresholds of |L2FC| > 1, FDR < 573 0.05. 574

The DEGs were divided into 2 gene sets according to their expression change status (cluster 1&2 576 for upregulated genes and cluster 3&4 for downregulated genes) as represented in Figure 7A . Then, 577 the putative TF-targeting regulons of these 2 gene sets were identified by employing RcisTarget 578

[65]. We choose human motif collection v9 as TF annotation and the motif-rankings in 10 kbp 579 around transcription start sites (TSS) of hg38 genome as region databases. The motifs with most target genes as well as a normalized enrichment score (NES) lager than 3 were determined as 581 significant enriched regulons. 582

We performed alternative splicing (AS) analysis based on transcription raw reads with vast-tools 584 V2.5. 1 [66] in combination with vastdb hs2.23.06.20. To determine significant AS events, we kept 585 the AS event which have more than 10 reads in at less two samples and applied a further filter by 586 setting a noB3 parameter to AltEx and a 0.05 binomial-test p_IR parameter to IR in vast-tools' diff 587 module. Significant AS events were defined according to the following requirements: change was 588 greater than 10 dPSI/dPIR, minimal difference value where P > 0.95 was greater than 0. Significant terms were chosen by the threshold that P value < 0.05, FDR (false-discovery rate) < 594 0.25 and |NES| > 1. Most significant terms were selected to plot heatmap. 595

The Over Representation Analysis (ORA) was based on the hypergeometric distribution and 596 We apologize to all colleagues whose work were unable to be cited and discussed due to space 620 constraints. We thank all colleagues whose excellent work helped us to understand and tackle the 621 Immunostaining was performed as in Figure S2A . reported phosphoproteome data were used as inputs to identify consistent phosphorylated peptides. 946

Analysis and color as Figure 3A . C. Cell cycle analysis of NSP3 expressing cells. Cells transfected 947 with indicated plasmids were harvest for FACS analysis using propidium iodide. Significant 948 differences compared to control cells were calculated using student t-tests. The graph showed 949 mean ± SD, n=3, * indicates p < 0.05, ** indicates p < 0.01. One representative experiment was 950

shown. D and E. Kinases inhibitors mapped to kinases whose activity mapped to DEPPs in CoV2-951

indicates downregulated activity. F. Hierarchical clustering of DEPPs that regulated by IKK-953 family and TBK1. Analysis and color as Figure 3A . 

CoV2 CoV2-NSP3   TTC33  THRAP3  SSBP3  YIPF3  HEATR1  KIF13B  MRPL27  HDGFRP3   DCAF5  DR1  ECD  EIF4B  FANCD2  HTATSF1   IPO5  MAGED2  OTUD4  PDXDC1  RCHY1  UBE2O  PABPC1  VDAC1  NUP153  SSR4  PPP2CA  REEP5  GPS1  PABPC4  TRIP12  SMC1A  PCM1  SLC35E1  CLCC1  TM9SF3  CHMP2B CoV2-NSP3 FAHD1  ADCK4  MRPS7  ECI1  MCAT  GRSF1  MRPL2  MRPL13  COQ7  MRPS28  MRPL15  MRPL23  VARS2  MRPL27  MRPS31  COQ9  MRPS18B  MRPL4  PYURF  ACAD9  TAMM41  MRPL43  MRPL37  MRPL28  UQCC2  MRPL16  NDUFS2  PTCD3  CPT2  MRPS26  NAP1L1  C1QBP  DDX28  CHDH  FECH  MRPL39  MRPL51  MRPS17  LETM1  GFM1  NAP1L4  IPO7  LRPPRC  TRAP1  MRPS22  DHX30  NIPSNAP1  L2HGDH  MRPS2  TIMM44  COQ3  MRPL50  MRPL24  COQ6  PEX19  MRPL46  NDUFAF7  MRPL3  COQ5  C2orf47  MRPS35  2-NSP3  MMGT1  PDCL  FMR1  FXR2  ERLIN2  FXR1  RNF5  UFL1  RPL13A  RPL36  RPL26  GIGYF2  RPL7  RPL8  RPL10A  RPL3  RPL4  RPL6  RPL7A  RPL14  RPL15  RPL19  RPL13  RPL28  RPL18  RPL34  RPL35  RPL17  RPL21  RPL27A  MIA3  L1RE1  RPL18A  RPL27  RCHY1  KTN1  EMC3  SSR1  RRBP1.1  EMC7  TMEM43  1-NSP3  ISCU  LARS2  IPO8  RCN2  IDH2  IVNS1ABP  MTHFD1L  PRPF31  DKFZp686E2459  PWP1  STK38L  STK38  EIF4B  WDR77  JAK1  PPM1B  C11orf84  SPIN1  PRMT5  SLC27A4   1 THRAP3_S408  THRAP3_S406  UBE2O_S87  UBE2O_S89  TOP2A_T1470   DNMT1_S714  PPIG_S717  C18orf25_S69  LARP4B_S731  SRSF1_S238  SRSF1_S234  SNRNP27_S63  ZNF687_S1085  ZNF687_S1082  MORC2_S730  JPH1_S216  JPH1_S220   TRA2A_T24  RANBP2_T2458  ALS2_S483  ALS2_S492  TOR1AIP1_S315  SIN3A_S832  SSRP1_S667  LEMD2_S499  KTN1_T153  DBN1_T346  CTTN_S418  SF1_S80  IWS1_S274  PARVA_S19  SRSF2_S212  SRSF2_S206  SRSF2_S208  SRCAP_S2869  SRRM2_S1674  TRIP12_S238  TRIP12_S241  PTPN12_S435  AEBP2_S206  UCK2_S254  CLASP2_S370   DDX55_S544  HMGA1_S103  HMGA1_S102  SLC4A4_T254  VPS35_S7   SRSF3_S128  SRSF3_S126  SRSF3_S130  ZC3H18_S857  SRSF7_S167  SRRM1_S530  CIC_S1397  SRRM2_S1598  SRRM2_S1657  SRRM2_S1658  JPH1_S469  RBBP6_S861  PRKD2_S197  CTU2_S508  HTATSF1_S391  RUNX1T1_T592  DBNL_S232  ABI1_S323  RUNX1T1_T595   CTR9_S941  CHD4_S108  MCM4_T110  SRRM2_T252  IWS1_S302  TAF6_S653  TAF6_T660  PCF11_S487  PDXDC1_S721  PDXDC1_S718  SRRM2_S449  SIPA1L1_S1647  SIPA1L1_S1645  SIPA1L1_S1649  SRRM2_S2407  GIT1_S596  IRF2BP2_S457  BAZ1B_S349  CEP170_S838  LARP4B_S736  CDK12_S359 

A Novel Coronavirus from Patients 632 with Pneumonia in China

Crystal structure of SARS-CoV-2 634 papain-like protease

Coronaviridae Study Group of the International Committee on Taxonomy of V. The species 636 Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it 637 SARS-CoV-2

A new coronavirus associated with 639 human respiratory disease in China

Epidemiology Working Group for Ncip Epidemic Response CCfDC, Prevention

Genomic characterisation and epidemiology 644 of 2019 novel coronavirus: implications for virus origins and receptor binding

WHO Declares COVID-19 a Pandemic

Viral targets for vaccines against COVID-19

Therapeutics and Vaccines: 650 Strengthening Our Fight Against the Global Pandemic COVID-19

The Architecture of SARS-CoV-2 653

Genomic characterization of the 655 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after 656 visiting Wuhan

Severe acute respiratory 658 syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles

SARS-coronavirus replication is supported by a reticulovesicular network of modified 662 endoplasmic reticulum

+)RNA viruses rewire cellular pathways to build replication 664 organelles

Nsp3 of coronaviruses: Structures and functions of a large 666 multi-domain protein

CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase

A noncovalent class 670 of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

Papain-like 673 protease regulates SARS-CoV-2 viral spread and innate immunity

Mechanism 675 and inhibition of the papain-like protease, PLpro, of SARS-CoV-2

A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-677

Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19

679 Characterization of protease activity of Nsp3 from SARS-CoV-2 and its <em>in vitro</em> 680 inhibition by nanobodies

Comprehensive analysis of the 682 host-virus interactome of SARS-CoV-2

Comparative host interactomes of the SARS-CoV-2 684 nonstructural protein 3 and human coronavirus homologs

Localization 689 of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late 690 endosomes in viral replication

Identification and characterization 692 of severe acute respiratory syndrome coronavirus replicase proteins

Mutation in murine coronavirus 694 replication protein nsp4 alters assembly of double membrane vesicles

Mouse 696 hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation

A SARS-CoV-2 699 protein interaction map reveals targets for drug repurposing

The reactome pathway 701 knowledgebase

Rapid 703 immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin 704 complexes

Multilevel proteomics 706 reveals host perturbations by SARS-CoV-2 and SARS-CoV

High-throughput and high-sensitivity 708 phosphoproteomics with the EasyPhos platform

Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2

Global Phosphorylation Landscape of SARS-CoV-2 Infection

KinMap: a web-based tool for interactive 715 navigation through human kinome data

Fostamatinib for the treatment of chronic immune thrombocytopenia

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a 720 Candidate for Rapid Repurposing for Acute Lung Injury

Specificity in Ubiquitination Triggered by Virus Infection

Broad and diverse mechanisms used by 724 deubiquitinase family members in regulating the type I interferon signaling pathway during 725 antiviral responses

Gene set 727 enrichment analysis: a knowledge-based approach for interpreting genome-wide expression 728 profiles

The Molecular 730 Signatures Database (MSigDB) hallmark gene set collection

p53 down-732 regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro 733 via E3 ubiquitin ligase RCHY1

CoV-2-infected host cells reveals therapy targets

Viral strategies for circumventing p53: the case of severe acute 737 respiratory syndrome coronavirus

Innate immunity during SARS-CoV-2: evasion 739 strategies and activation trigger hypoxia and vascular damage

SARS-CoV2 drives JAK1/2-742 dependent local and systemic complement hyper-activation

The potential of JAK/STAT pathway inhibition by ruxolitinib 744 in the treatment of COVID-19

JAK 746 inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce 747 morbidity and mortality

A systemic and molecular 749 study of subcellular localization of SARS-CoV-2 proteins

RNA-GPS Predicts SARS-CoV-2 RNA 752 Residency to Host Mitochondria and Nucleolus

Fine-tuning BMP7 754 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6

An 757 Interaction Landscape of Ubiquitin Signaling

The MaxQuant computational platform for mass spectrometry-759 based shotgun proteomics

Proteome-wide 761 identification of ubiquitin interactions using UbIA-MS

Accurate protein complex retrieval by affinity enrichment 763 mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS)

ReactomeFIViz: a Cytoscape app for pathway 766 and network-based data analysis

clusterProfiler: an R package for comparing biological 768 themes among gene clusters

circlize Implements and enhances circular 770 visualization in R

The KSEA App: a web-based tool for kinase activity 772 inference from quantitative phosphoproteomics

GPS 5.0: An Update on the Prediction 774 of Kinase-specific Phosphorylation Sites in Proteins

Graph-based genome alignment and 777 genotyping with HISAT2 and HISAT-genotype

StringTie enables 779 improved reconstruction of a transcriptome from RNA-seq reads

edgeR: a Bioconductor package for differential 781 expression analysis of digital gene expression data